We found that circulating plasma IP-10 levels were significantly higher in patients with NAFLD alone (P < 0.001) and in patients with NAFLD and incident diabetes (P < 0.001) than in controls. This evidence concerns the gene CXCL10 and metabolic dysfunction-associated steatotic liver disease.